Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
11,542 total articles
RYVYL Inc. announced that 99% of votes cast at its Special Shareholder Meeting support the planned merger with RTB Digital, Inc. The company needs just an additional 5% vote to exceed 50% of outstanding shares to complete the merger. The meeting was adjourned and will reconvene virtually on April 1, 2026, to finalize votes and merger approval. The …
The Lovesac Company announced an expansion of its share repurchase authorization by $40 million, increasing the total buyback program to approximately $54.1 million. The initiative demonstrates the company's confidence in its growth prospects and financial health, supported by a strong balance sheet and credit facility. The buybacks will be funded …
Upstream Bio announced its plans to initiate Phase 3 clinical trials of verekitug in severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) starting Q1 2027, following positive Phase 2 trial results that showed significant efficacy improvements. The company reported strong top-line data from the VALIANT trial in severe asthma and reinf…
USA Rare Earth (USAR) has successfully commissioned its commercial magnet production line at the Stillwater, Oklahoma facility, enabling shipment of sintered neodymium-iron-boron permanent magnets starting in Q2 2026. The company expects to ramp Phase 1a capacity to 600 metric tons per annum by Q4 2026 and reach 1,200 mtpa with Phase 1b by Q1 2027,…
Gain Therapeutics reported its financial results for Q4 and full-year 2025, highlighting significant progress with its lead drug candidate GT-02287 for Parkinson's disease. Positive Phase 1b clinical data indicates disease-modifying potential, with stable clinical scores and biomarker improvements. The company plans to initiate Phase 2 trials in th…
HOOKIPA Pharma announced the completion of the sale of its immuno-oncology assets, including the HB-200 and HB-700 development programs, to NeoTrail Therapeutics. The transaction closes the sale agreement signed in January 2026. HB-200 and HB-700 are investigational immunotherapies targeting HPV16 positive cancers and KRAS-mutated cancers respectiv…
The Lovesac Company (NASDAQ: LOVE) announced financial results for fiscal 2026 with net sales increasing modestly by 2.4% to $697.1 million. Despite revenue growth driven by showroom expansion and slight comps rise, the company experienced decreases in gross profit and net income compared to fiscal 2025, impacted by increased transportation and tar…
Acumen Pharmaceuticals reported financial results for 2025, highlighting progress on its lead Alzheimer's treatment candidate sabirnetug (ACU193), including anticipation of topline Phase 2 ALTITUDE-AD study results in late 2026 and expected IND filing for its Enhanced Brain Delivery program in mid-2027. The company secured $35.75 million in private…
MapLight Therapeutics reported strong progress in its Phase 2 clinical programs, including near-completion of enrollment for the schizophrenia ZEPHYR trial and completion of enrollment for the autism spectrum disorder IRIS trial, with topline data expected in Q3 2026. The company received FDA Fast Track designation for its Alzheimer's disease psych…
Sportradar has deepened its multi-year partnership with Hard Rock Bet in the U.S. by integrating official PGA TOUR and Ultimate Fighting Championship data, enhancing in-play betting capabilities and offering dynamic micro markets and advanced visualizations to users. This expansion leverages Sportradar’s recent acquisition of IMG ARENA rights for P…
Tonix Pharmaceuticals has dosed the first participant in a Phase 1 study evaluating TNX-1900, an intranasal potentiated oxytocin formulation, in healthy volunteers to assess its potential for treating migraine and craniofacial pain by inhibiting CGRP release through a novel pathway. The study uses advanced Laser Speckle Contrast Imaging (LSCI) to m…
Hyperion DeFi, Inc., the first U.S. publicly listed DeFi company on Hyperliquid, announced robust financial results for Q4 and FY 2025. The company exceeded Q4 guidance with 64% revenue growth and 87% growth in adjusted gross profit quarter-over-quarter. It operates five diversified DeFi business lines, including staking, validator commissions, yie…
Ligand Pharmaceuticals has expanded its business development team by hiring two seasoned healthcare investors, Peter Renehan, MD and Lee Brown, and promoting Lauren Hay to Vice President of Portfolio Strategy and Investments. These hires aim to enhance Ligand's ability to source and execute royalty financing opportunities, supporting long-term valu…
Tilray Brands has announced a new licensing agreement with The Magnum Ice Cream Company to produce and distribute ready-to-drink Popsicle Hard beverages, featuring classic Popsicle flavors with 5% alcohol by volume. The product line, including Hard Cherry, Hard Orange, Hard Grape, and a seasonal Hard Firecracker flavor, targets the US adult beverag…
Lifecore Biomedical announced two new contract development and manufacturing organization (CDMO) agreements with an existing U.S.-based biopharmaceutical customer. The agreements include a site transfer for manufacturing a currently marketed product and expansion of manufacturing to a second delivery system for an ophthalmic treatment. These deals …
WeShop Holdings Limited, a US-listed social commerce platform, announced the launch of its Founders Programme in the UK. The initiative aims to empower early community creators by offering them increased referral rewards, exclusive events, and direct engagement opportunities to help grow the platform. This move is part of WeShop's strategy to accel…
Agomab Therapeutics announced that the USPTO granted a composition of matter patent for AGMB-447, its inhaled lung-restricted ALK5 inhibitor in development for idiopathic pulmonary fibrosis (IPF). This patent protection extends in the U.S. through at least 2041, supporting the company's clinical-stage pipeline targeting fibrosis. AGMB-447 is curren…
Kamada Ltd., a global biopharmaceutical leader in specialty plasma-derived therapies, announced FDA approval of its new plasma collection center in San Antonio, Texas. The facility can collect up to 50,000 liters of plasma annually, with expected revenues of $8-10 million at full capacity. This center will enhance Kamada's plasma collection capabil…
Cibus, Inc., an agricultural technology company specializing in gene-edited plant traits, has priced a public offering of nearly 7 million Class A shares at $2.15 each, aiming to raise approximately $15 million before expenses. The proceeds will be used for working capital and to advance development of weed management traits in rice. The offering i…
TransUnion announced the release date for its first quarter 2026 financial results on April 28, 2026. The company will publish a press release at 6:00 a.m. CT followed by a conference call at 8:30 a.m. CT to discuss its earnings. TransUnion is a global information and insights company specializing in credit data, fraud prevention, marketing, risk, …
KANZHUN LIMITED, trading as BOSS Zhipin on Nasdaq, announced ongoing execution of its share repurchase program, spending approximately RMB34.4 million to buy back 748,460 ordinary shares on March 25, bringing total repurchases in 2026 to over RMB480 million. This action reflects the company's commitment to enhance shareholder value.
Comstock Inc. announces its 2026 Annual Meeting of Shareholders to be held on May 28, 2026, in Reno, Nevada. The meeting will cover topics including Comstock Metals, strategic investments, and clean energy systems. The company emphasizes its focus on innovating technologies to recycle metals from end-of-life photovoltaics. The notice includes detai…
22nd Century Group, a Nasdaq-listed company specializing in reduced nicotine tobacco products, reported fourth quarter and full year 2025 results showing strategic progress in expanding its proprietary VLN® low nicotine cigarette product across more retail outlets and states, elimination of $8 million legacy debt, and a strong year-end cash positio…
Abercrombie & Fitch's brand Hollister teams up with singer-songwriter Gigi Perez to release a reimagined version of Green Day's 'Good Riddance (Time of Your Life)' as part of a graduation season campaign. The initiative includes an original music video featuring young creatives and a new product collection themed around milestone moments, aimed at …
GRAVITY Co., Ltd. announced the official launch of Ragnarok Origin Classic, a multi-platform MMORPG available on PC and mobile devices, in Korea, Taiwan, Hong Kong, Macau, and Southeast Asia on March 26, 2026. The game features a monthly pass system and revamped combat design to enhance player engagement by focusing on skill and strategy, aiming to…
